26 results
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
with Community-Acquired ... fluoroquinolone #IDSA ... #Community #Acquired ... Treatment #Regimen #Management ... #Guidelines #pharmacology
Algorithm for assessment and management of community acquired pneumonia (CAP) #Management #Peds #PrimaryCare #CommunityAcquiredPneumonia #CAP #Protocol
assessment and management ... of community acquired ... pneumonia (CAP) ... #Management #Peds ... CommunityAcquiredPneumonia #CAP
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
hydroxychloroquine, thought we can ... treatments for COVID ... InfectiousDiseases #COVID19 ... Coronavirus #Treatment #Management ... #Pharmacology #
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe COVID ... anti-IL6R mAb) Dose can ... #Pharmacology # ... Management #Medications
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
the Treatment of COVID ... in someone who had ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... be community-acquired ... (IDSA 2021): ... /severe CDI IDSA ... infectiousdiseases #IDSA
Protected Airway Intubation Pre-Brief Checklist - COVID19

1. ROLE ASSIGNMENT
2. PPE: Extended gloves, BLUE gown, N95, face
Pre-Brief Checklist - COVID19 ... shield, bouffant cap ... MEDS & EQUIPMENT ... Intubation #Checklist #COVID19 ... #CriticalCare #Management
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
anidulafungin; CAS ... fluconazole; ISA ... #antibiogram #management ... #pharmacology #
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... antifungals are required ... candida #mucosal #IDSA ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Neonatal Resuscitation – Circulation and Drugs
Consider drugs (k) if heart rate beats/min in spite of adequate
vasoconstriction may have had ... negative blood is required ... #Medications #Pharmacology ... #management #peds